What is USIOL?
USIOL specializes in the production of high-quality intraocular lenses, injectors, viscoelastic gels, and sutures, serving ophthalmologists worldwide. The company emphasizes stringent quality control, evidenced by its FDA registration and ISO 13485 certification. This commitment to regulatory standards ensures the reliability and safety of its product portfolio, positioning USIOL as a dependable supplier in the competitive ophthalmic market. Their offerings are critical for vision correction procedures, supporting both surgical efficacy and patient outcomes.
How much funding has USIOL raised?
USIOL has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in USIOL
PPP
Public-Private Partnership
What's next for USIOL?
The recent strategic investment signals a phase of potential expansion or technological advancement for USIOL. Given its established history and focus on core ophthalmic surgical supplies, this capital infusion is likely to support scaling manufacturing capabilities, enhancing research and development for next-generation intraocular lenses, or broadening its global distribution network. The company's late-stage funding context suggests a mature operational footprint poised for significant growth or strategic partnerships.
See full USIOL company page
